Skip to main content

September 2022

 

 

academics

 

Clinical research courses

IPC to add 8 chemical monographs and 7 Veterinary Monograph

Indian Pharmacopoeia commission (IPC) to add 8 chemical monographs and 7 Veterinary Monographs and open them for Public Review and Comments.

IPC to add chemical monographs which include, Aceclofenac and paracetamol Tablets, Azacitidine for Injection, Ethamsylate, Lactulose Solution, Atropine Ophthalmic solution, Moxifloxacin Tablets, Remogliflozin Etabonate and Remogliflozin Tablets.

Lupin Launches Generic Suprep Bowel Prep Kit in the United States

Global pharma major Lupin Limited announced the launch of Sodium Sulfate, Potassium Sulfate and Magnesium Sulfate Oral Solution, 17.5 g/3.13 g/1.6 g per 6 ounces, having received an approval from the United States Food and Drug Administration (FDA).

Sodium Sulfate, Potassium Sulfate and Magnesium Sulfate Oral Solution, 17.5 g/3.13 g/1.6 g per 6 ounces is a generic equivalent of Suprep Bowel Prep Kit Oral Solution, 17.5 g/3.13 g/1.6 g per 6 ounces, of Braintree Laboratories Inc.

Zydus in-licenses a critical drug for CKD patients from Pharmacosmos A/S of Denmark

Zydus Lifesciences Ltd., an innovation-driven global life sciences announced that it has acquired rights to market MonoFerric  (iron isomaltoside) injections in India and Nepal from Denmark based Pharmacosmos A/S. MonoFerric , iron isomaltoside 1000 solution for injection/infusion, is a rapid, single dose IV iron (up to 20 mg/kg bodyweight) developed to reduce the number of infusions required to achieve iron correction with an excellent safety profile.

IPA gives clean chit to Micro Labs

Indian Pharmaceutical Alliance (IPA) gives clean chit to Micro Labs, Dolo maker, against a case on Rs. 1,000 crores in freebies to doctors, and states that the company is following the processes as per the Uniform Code of Pharmaceutical Marketing Practices, UCPMP, guidelines.

Novartis Cosentyx shows improvement in hidradenitis suppurativa in trials

Novartis announced the results from two pivotal, Phase III studies, in which Cosentyx (secukinumab) demonstrated rapid and sustained relief from the common clinical signs and symptoms of moderate-to-severe hidradenitis suppurativa (HS) with a favorable safety profile.

The data were presented as a late-breaking abstract at the 31st European Academy of Dermatology and Venereology (EADV) Congress.

Vacancy for M.Pharm, M.Sc as Facility Assistant at Centre for Cellular and Molecular Platforms

Centre for Cellular and Molecular Platforms (C-CAMP), is a Dept. of Biotechnology (Govt. of India) initiative and a not for profit organization based in Bangalore. We act as an enabler of Bioscience Research, Innovation and Entrepreneurship by providing Research, Development, Training and Services in State Of The Art Technology Platforms.

Job opening for M.Pharm or MSc as Program Manager at THSTI - Pay Rs. 1,00,000 pm

Translational Health Science and Technology Institute (THSTI) is an autonomous Institute of the Department of Biotechnology, Ministry of Science and Technology, Govt. of India. The institute is an integral part of the interdisciplinary NCR Biotech Science Cluster located at Faridabad, and is designed as a dynamic, interactive organization with the mission to conduct innovative translational research and to develop research collaborations across disciplines and professions to translate concepts into products to improve human health.

M.Pharm Job for SERB Funded Project at Birla Institute of Technology and Science

Birla Institute of Technology and Science, Pilani  - Hyderabad campus is one of the premier technical and science institutes of higher learning in India. It was established by Birla Institute of Technology and Science, Pilani (Rajasthan) as one of its latest campuses in the year 2008 with the first batch graduating in the year 2012. BITS, Pilani is one of India’s top technical and science universities  established under Sec. 3 of the UGC act. 

Recruitment of Pharmacist at National Institute of Ayurveda | Pay upto Rs. 92,300 pm

National Institute of Ayurveda, Deemed to be University (De novo) is an apex autonomous Institute under the aegis of Ministry of AYUSH, Government of India. NIA was conferred the Deemed to be University status under De novo category and was dedicated to the Nation by the Honourable Prime Minister of India, Shri Narendra Modi on 13th Novemeber 2020 ( 5th Ayurveda Day).  NIA is the first Central Government funded Institute to be declared as Deemed to be University in the field of Ayush.

Job as Senior Scientific Reviewer at Pfizer | M.Pharm, M.Sc Apply

Pfizer is the world's premier biopharmaceutical company taking new approaches to better health.  We discover, develop, manufacture and deliver quality, safe and effective prescription medicines to treat and help prevent disease for both people and animals. We also partner with healthcare providers, governments and local communities around the world to expand access to our medicines and to provide better quality health care and health system support.